Benzinga | Feb 23, 2021 06:32AM EST

Epizyme Q4 EPS $(0.65) Misses $(0.58) Estimate, Sales $8.40M Beat $6.19M Estimate

Epizyme (NASDAQ:EPZM) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.58) by 12.07 percent. This is a 10.17 percent decrease over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $8.40 million which beat the analyst consensus estimate of $6.19 million by 35.70 percent. This is a 95.62 percent increase over sales of $4.29 million the same period last year.